Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · IEX Real-Time Price · USD
29.50
-0.26 (-0.87%)
At close: Jul 19, 2024, 4:00 PM
29.56
+0.06 (0.20%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $1.50 billion as of July 22, 2024. Its market cap has increased by 4,306.12% in one year.
Market Cap
1.50B
Enterprise Value
1.01B
1-Year Change
4,306.12%
Ranking
Category
Stock Price
$29.50
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $1.50B, an increase of 1,241.16%. That is a compound annual growth rate of 36.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.19B | 1,264.41% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Schrödinger | 1.55B |
| Alphatec Holdings | 1.55B |
| Teladoc Health | 1.54B |
| Kiniksa Pharmaceuticals | 1.51B |
| Belite Bio | 1.50B |
| InMode | 1.50B |
| Tilray Brands | 1.48B |
| Brookdale Senior Living | 1.48B |